ClinicalTrials.govpublic full text
Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC
oral squamous cell carcinoma, neoadjvant therapy, anti-pd-1, chemotherapy, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 829118
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.